Back to directory
Isomorphic Labs
Builds AI platforms accelerating drug discovery and molecular design.
🇬🇧 United KingdomLondonFounded 2021$601.7M101-250 employeesSeries AArtificial Intelligence (AI)BiotechnologyLife ScienceMedicalWebsite
About
Isomorphic Labs focuses on drug discovery using artificial intelligence, developing platforms that analyze biological data to identify potential drug candidates.
Founders
Demis HassabisMiles CongreveSergei Yakneen